Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted
10 Agosto 2023 - 9:00AM
Business Wire
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI; NASDAQ: OGI), announced today that the Federal Court of Canada
(the “Court”) has granted Organigram’s application for judicial
review of a decision of Health Canada determining that the Edison
Jolts lozenges (the “Products”) are to be classified as edible
cannabis. The Court found there was a breach of procedural fairness
by Health Canada. The matter is being remitted back to Health
Canada for redetermination taking the Court’s reasons into
consideration.
“We are pleased with the outcome of the hearing and look forward
to Health Canada’s further review of our Jolts ingestible extract,”
said Beena Goldenberg, CEO of Organigram. “Our unprecedented
approach in this matter reaffirms our commitment to advocating for
the matters that impact our industry the most as we strive to build
a thriving legal cannabis sector capable of combatting the illicit
market,” she concluded.
The Company launched the Products in August 2021 following
significant research, development, and regulatory work. The Company
remains of the view that the patent pending Products are properly
classified as cannabis extracts and compliant with the Cannabis
Regulations.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc. and Laurentian Organic Inc., licensed producers of
cannabis and cannabis-derived products in Canada, and The Edibles
and Infusions Corporation, a licensed manufacturer of
cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company’s global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230810958983/en/
For Investor Relations enquiries:
Max Schwartz Director of Investor Relations
investors@organigram.ca Organigram
For Media enquiries:
Megan McCrae Senior Vice President – Marketing and
Communications megan.mccrae@organigram.ca Organigram
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024